Natera, Inc. cash flow statement
In fiscal 2025, Natera, Inc.'s operations generated $215m of cash; it spent $106m on capital projects, leaving free cash flow of $109m.
Cash flow statement
| Fiscal year | 2013Dec 2013 | 2014Dec 2014 | 2015Dec 2015 | 2016Dec 2016 | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | −24 | 10 | −38 | −74 | −98 | −71 | −63 | −183 | −335 | −432 | −247 | 136 | 215 | 228 |
| Depreciation and amortisation | 3 | 5 | 6 | 6 | 7 | 8 | 8 | 9 | 11 | 17 | 24 | 31 | 42 | 50 |
| Stock-based pay | 2 | 5 | 7 | 11 | 11 | 14 | 29 | 50 | 115 | 152 | 192 | 274 | 354 | 381 |
| Capital spending | 8 | 10 | 8 | 23 | 10 | 4 | 5 | 20 | 41 | 48 | 39 | 66 | 106 | 144 |
| Free cash flow | −32 | 1 | −46 | −97 | −108 | −74 | −68 | −202 | −376 | −479 | −286 | 69 | 109 | 84 |
| Free cash flow after stock pay | −34 | −5 | −53 | −108 | −119 | −89 | −97 | −252 | −491 | −632 | −478 | −205 | −245 | −297 |
| Shares issued | — | — | — | — | — | 97 | — | — | — | — | — | — | — | — |
| Quarter | 2024 Q3Sept 2024 | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | 52 | 53 | 44 | 38 | 59 | 74 | 40 | 55 |
| Depreciation and amortisation | 8 | 8 | 9 | 9 | 10 | 12 | 15 | 13 |
| Stock-based pay | 71 | 72 | 78 | 93 | 91 | 93 | 95 | 103 |
| Capital spending | 16 | 18 | 22 | 26 | 22 | 36 | 22 | 63 |
| Free cash flow | 35 | 35 | 23 | 12 | 37 | 38 | 18 | −9 |
| Free cash flow after stock pay | −35 | −37 | −55 | −82 | −54 | −55 | −77 | −112 |
Compare with peers
- Exelixis, Inc. cash flow
- United Therapeutics Corp cash flow
- Biontech SE cash flow
- Moderna cash flow
- Biomarin Pharmaceutical Inc cash flow
Head to head: EXEL vs NTRANTRA vs UTHRBNTX vs NTRAMRNA vs NTRA
More: Biotechnology stocks compared, Health Care sector, rankings of US companies